ELISA Kit for Breast Cancer Susceptibility Protein 1 (BRCA1)

BRCAI; BRCC1; IRIS; PSCP; RNF53; Breast Cancer 1,Early Onset; RING finger protein 53

Specificity

This assay has high sensitivity and excellent specificity for detection of Breast Cancer Susceptibility Protein 1 (BRCA1).
No significant cross-reactivity or interference between Breast Cancer Susceptibility Protein 1 (BRCA1) and analogues was observed.

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Breast Cancer Susceptibility Protein 1 (BRCA1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Breast Cancer Susceptibility Protein 1 (BRCA1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Intl. J. Biolog. Pharmaceutic. Res. IN VITRO EFFECT OF RESVERATROL ON DNA METHYLATION AND BRCA1 EXPRESSION IN MCF-7 HUMAN BREAST CANCER CELLS Publication: 281344291
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPB376Hu01 Recombinant Breast Cancer Susceptibility Protein 1 (BRCA1) Positive Control; Immunogen; SDS-PAGE; WB.
PAB376Hu01 Polyclonal Antibody to Breast Cancer Susceptibility Protein 1 (BRCA1) WB; IHC; ICC; IP.
LAB376Hu71 Biotin-Linked Polyclonal Antibody to Breast Cancer Susceptibility Protein 1 (BRCA1) WB; IHC; ICC.
MAB376Hu22 Monoclonal Antibody to Breast Cancer Susceptibility Protein 1 (BRCA1) WB; IHC; ICC; IP.
SEB376Hu ELISA Kit for Breast Cancer Susceptibility Protein 1 (BRCA1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB376Hu Multiplex Assay Kit for Breast Cancer Susceptibility Protein 1 (BRCA1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.